X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

FASEB JOURNAL

期刊標題檢索 FASEB J 最新評論: The paper was published on 24.11.30, and on 24.12.03, I received a... (2024-12-05)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[FASEB JOURNAL]您好,您是該頁面的第 273833 位訪客。

期刊簡介
期刊名稱FASEB JOURNAL FASEB JOURNAL
LetPub Score
8.0
53 ratings
Rate

Reputation
8.6

Influence
7.3

Speed
8.6

期刊簡稱FASEB J
ISSN0892-6638
E-ISSN1530-6860
h-index257
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.201.4120.917
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Genetics
Q156 / 347
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biochemistry
Q176 / 438
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Biotechnology
Q155 / 311
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Biology
Q190 / 410

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
The FASEB Journal publishes international, transdisciplinary research covering all fields of biology at every level of organization: atomic, molecular, cell, tissue, organ, organismic and population. While the journal strives to include research that cuts across the biological sciences, it also considers submissions that lie within one field, but may have implications for other fields as well. The journal seeks to publish basic and translational research, but also welcomes reports of pre-clinical and early clinical research. In addition to research, review, and hypothesis submissions, The FASEB Journal also seeks perspectives, commentaries, book reviews, and similar content related to the life sciences in its Up Front section.
官方網站https://www.fasebj.org
在線稿件提交
開放訪問No
出版商FASEB
主題領域生物
出版國/地區UNITED STATES
發行頻率月刊
創刊年1987
每年文章數636每年文章數趨勢
黃金OA百分比30.82%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
BIOCHEMISTRY & MOLECULAR BIOLOGYSCIEQ282/313
BIOLOGYSCIEQ115/109
CELL BIOLOGYSCIEQ277/205
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0892-6638%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【FASEB JOURNAL】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE MEDICINEH-index: 497

    CiteScore: 100.90
    CELLH-index: 705

    CiteScore: 110.00
    Molecular CancerH-index: 103

    CiteScore: 54.90
    Molecular PlantH-index: 85

    CiteScore: 37.60
    NUCLEIC ACIDS RESEARCHH-index: 452

    CiteScore: 27.10
    Molecular CellH-index: 356

    CiteScore: 26.00
    PROGRESS IN LIPID RESEARCHH-index: 132

    CiteScore: 24.50
    TRENDS IN MICROBIOLOGYH-index: 172

    CiteScore: 25.30
    CELL DEATH AND DIFFERENTIATIONH-index: 193

    CiteScore: 24.70
    Nature Chemical BiologyH-index: 182

    CiteScore: 23.90
    學科內最受檢索的期刊 頁面查看次數
    International Journal of Biological Macromolecules1415935
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS579230
    JOURNAL OF BIOLOGICAL CHEMISTRY396435
    NUCLEIC ACIDS RESEARCH345600
    CELL298929
    International Journal of Biological Sciences244912
    Molecular Cancer244681
    PLANT SCIENCE228497
    ONCOGENE206890
    NATURE MEDICINE196760
  •  

    FASEB JOURNAL FASEB JOURNAL
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/31)
  [FASEB JOURNAL] 的評論撰寫評論
作者: 白云葛菲


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 13:40:43 評論於
Research emphasis: Cardiovascular Experience sharing: After submission, the status shows "Quality control check underway". Later, I received an email about sciscorc, and the status still shows "Quality control check underway". What is going on? Do I need to change any content? What should I do next?
(0) 讚! | 白云葛菲

作者: 白云葛菲


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-19 08:54:48 評論於
How is your manuscript going? I received an email about sciscore, what should I do next?
(0) 讚! | 白云葛菲

作者: 龙爪春雷


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-10 08:42:46 評論於
How to send a withdrawal email? I just submitted an article and now I want to withdraw it to submit to another journal
(0) 讚! | 龙爪春雷

作者: 白云葛菲


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-05 15:24:44 評論於
Research focus: Cardiovascular experiences sharing: I am currently undergoing a Quality control check, and just recieved an email about sciscore. Do I need to make any changes? Or should I wait for submission?
(0) 讚! | 白云葛菲

作者: 吐纳尔安


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-08 13:31:25 評論於
Have you paid yet? I have the same question
(0) 讚! | 吐纳尔安

作者: Freda Morrison


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-06 20:29:59 評論於
Bias research focus: Tumor biology
Sharing experience: After submitting a post with your own account, is it necessary to send it to the corresponding author as the final step? I see there is a button for this, but it doesn't say it's required
(0) 讚! | Freda Morrison

作者: 四风翰池


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-03 11:01:11 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Emphasized research direction: Molecular biology
Experience sharing: The article was submitted multiple times, and the score decreased from 8 to 5. This editor and reviewer seem to like our research very much, and they accepted it directly after minor revisions
(0) 讚! | 四风翰池

作者: 血天梦菡


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-07 12:17:39 評論於
Have you paid for this issue?
(0) 讚! | 血天梦菡

作者: 血天梦菡


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-07 10:57:06 評論於
This is the information in the journal. Authors choose whether to publish as immediate open access with CC-BY, CC-BY-NC, or CC-BY-NC-ND licenses or under the traditional page charge option with subscription access, and no longer pay both fees. The journal is included in transitional arrangements with many institutions through Wiley
(0) 讚! | 血天梦菡

作者: 血天梦菡


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-07 09:37:52 評論於
Is his invoice provided in PDF format?
(0) 讚! | 血天梦菡

作者: 西风敦牂


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-05 21:05:16 評論於
Do I need to pay the review fee now?
(0) 讚! | 西风敦牂

作者: 西风敦牂


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-05 08:52:04 評論於
Me too! I was so nervous, but my junior brother submitted for review a week later than me
(0) 讚! | 西风敦牂

作者: 西风敦牂


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-01 11:22:48 評論於
Do I still need to pay the review fee now? Where can I pay it? My submission has been under consideration for fifteen days
(0) 讚! | 西风敦牂

作者: 西风敦牂


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-01 10:27:06 評論於
Do I need to pay a $50 review fee now?
(0) 讚! | 西风敦牂

作者: 南风怡嘉


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-30 20:56:21 評論於
Please translate the following passage into English and Japanese, and label them as ":" and ":"
(0) 讚! | 南风怡嘉

作者: 是你的凝绿呀


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-26 20:54:51 評論於
Have you made the payment? Is it possible that after some time of being online, Wiley sends an email asking for payment?
(0) 讚! | 是你的凝绿呀

作者: 虎鹤天云


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-02 11:23:17 評論於
I'm already online
(0) 讚! | 虎鹤天云

作者: 璃沙芝英


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-15 12:47:03 評論於
Review Speed: 6.0 | Submission Hit Rate: 75.0
Experience Sharing: Submitted a review article which took about 5 months. Made some minor revisions in the middle. Chose the traditional subscription model. After the proofreading, it was successfully published online. However, about two weeks later, received an invoice for $2940. Checked the official website and it seems that there is indeed a page fee to be paid. I was deceived by the public account, thinking that there was no page fee involved when submitting. The impact factor has also dropped to below 5. Starting to doubt if it's a scam email, but the address and other information seem to be correct. Can't find any evidence, so planning to pay the money in a few days
(0) 讚! | 璃沙芝英

作者: hao4269


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-14 18:12:23 評論於
Hello, OP. I submitted my post on August 21 (first submission), and it is still "Under consideration" today. Based on your previous experience, I am wondering if this status indicates that it is with the editor, or if it has already been sent for review? Thank you for your response
(0) 讚! | hao4269

作者: 晨风星鹏


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-13 15:58:50 評論於
Did you win in the end?
(0) 讚! | 晨风星鹏

作者: Lxk_75656


領域: 生物学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-09-12 00:38:27 評論於
Yes, I choose OA
(0) 讚! | Lxk_75656

作者: 友梅酱大魔王


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-08 15:41:31 評論於
Asked the same question, didn't choose OA, the article is already online, but received an invoice for $2940? Seriously doubt if it's a scam
(0) 讚! | 友梅酱大魔王

作者: 虎鹤天云


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-08 10:15:34 評論於
Hello, I just wanted to ask you about the process of receiving an email that says "The corresponding author will receive an email from Wiley Author Services containing instructions on how to register, log in, and complete the licensing and signature process for your article. You can choose from various standard and open access licensing options." How did you handle this step? Can I contact you for more information?
(0) 讚! | 虎鹤天云

作者: 金刚乐人


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-04 20:09:25 評論於
Hello, how long does it take for a decision to be made after the second review is under consideration?
(0) 讚! | 金刚乐人

作者: Amanda Bennett


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-04 14:10:02 評論於
Is the author clear about the fees for this layout? I am also facing the same issue now, selected the subscription, but Wiley requires us to pay $2800
(0) 讚! | Amanda Bennett

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/31)

開始撰寫 [FASEB JOURNAL] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*